Bloodstream infections and patient survival with tunneled-cuffed catheters for hemodialysis: A single-center observational study.


Journal

The International journal of artificial organs
ISSN: 1724-6040
Titre abrégé: Int J Artif Organs
Pays: United States
ID NLM: 7802649

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 28 4 2020
medline: 2 3 2021
entrez: 28 4 2020
Statut: ppublish

Résumé

In hemodialysis patients, a tunneled-cuffed permanent catheter is mandatory when the arteriovenous fistula is not feasible. The major risks of the use of tunneled-cuffed permanent catheter are bloodstream infections. The aim of this study is to analyze bloodstream infections from tunneled-cuffed permanent catheter in hemodialysis patients. An observational prospective study was carried out and 79 hemodialysis patients with tunneled-cuffed permanent catheter were enrolled. Patients were divided into those with bloodstream infections from tunneled-cuffed permanent catheter and those without. Their clinical and laboratory characteristics were compared. An original tunneled-cuffed permanent catheter lock therapy sequence was carried out combined with systemic antibiotic therapy. In case of antibiotic resistance, the tunneled-cuffed permanent catheter was removed. The patients affected by bloodstream infections from tunneled-cuffed permanent catheter were 16/79 (20.3%). The bloodstream infection from tunneled-cuffed permanent catheter's incidence rate was 0.52 per 1000 catheter days. Twenty-three bloodstream infections from tunneled-cuffed permanent catheter were found in 16/79 patients who used tunneled-cuffed permanent catheter. The enrolled cohort showed a reduced bloodstream infection from tunneled-cuffed permanent catheter incidence rate in comparison with the reference value (1 per 1000 catheter days). To reduce the number of bloodstream infections from tunneled-cuffed permanent catheter, hand hygiene and asepsis management of the tunneled-cuffed permanent catheter during the connection to the extracorporeal circuit and an original tunneled-cuffed permanent catheter lock therapy sequence seem to be the most efficient measures. Infections of other organs and the presence of peripheral obstructive arterial disease are the most important risk factors for bloodstream infections from tunneled-cuffed permanent catheter.

Sections du résumé

BACKGROUND BACKGROUND
In hemodialysis patients, a tunneled-cuffed permanent catheter is mandatory when the arteriovenous fistula is not feasible. The major risks of the use of tunneled-cuffed permanent catheter are bloodstream infections. The aim of this study is to analyze bloodstream infections from tunneled-cuffed permanent catheter in hemodialysis patients.
METHODS METHODS
An observational prospective study was carried out and 79 hemodialysis patients with tunneled-cuffed permanent catheter were enrolled. Patients were divided into those with bloodstream infections from tunneled-cuffed permanent catheter and those without. Their clinical and laboratory characteristics were compared. An original tunneled-cuffed permanent catheter lock therapy sequence was carried out combined with systemic antibiotic therapy. In case of antibiotic resistance, the tunneled-cuffed permanent catheter was removed.
RESULTS RESULTS
The patients affected by bloodstream infections from tunneled-cuffed permanent catheter were 16/79 (20.3%). The bloodstream infection from tunneled-cuffed permanent catheter's incidence rate was 0.52 per 1000 catheter days. Twenty-three bloodstream infections from tunneled-cuffed permanent catheter were found in 16/79 patients who used tunneled-cuffed permanent catheter.
CONCLUSION CONCLUSIONS
The enrolled cohort showed a reduced bloodstream infection from tunneled-cuffed permanent catheter incidence rate in comparison with the reference value (1 per 1000 catheter days). To reduce the number of bloodstream infections from tunneled-cuffed permanent catheter, hand hygiene and asepsis management of the tunneled-cuffed permanent catheter during the connection to the extracorporeal circuit and an original tunneled-cuffed permanent catheter lock therapy sequence seem to be the most efficient measures. Infections of other organs and the presence of peripheral obstructive arterial disease are the most important risk factors for bloodstream infections from tunneled-cuffed permanent catheter.

Identifiants

pubmed: 32339055
doi: 10.1177/0391398820917148
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

767-773

Auteurs

Gabriele Donati (G)

Department of Experimental Diagnostic and Specialty Medicine (DIMES); Nephrology, Dialysis and Renal Transplant Unit, St. Orsola University Hospital, University of Bologna, Italy.

Alessandra Spazzoli (A)

Department of Experimental Diagnostic and Specialty Medicine (DIMES); Nephrology, Dialysis and Renal Transplant Unit, St. Orsola University Hospital, University of Bologna, Italy.

Anna Laura Croci Chiocchini (AL)

Department of Experimental Diagnostic and Specialty Medicine (DIMES); Nephrology, Dialysis and Renal Transplant Unit, St. Orsola University Hospital, University of Bologna, Italy.

Anna Scrivo (A)

Department of Experimental Diagnostic and Specialty Medicine (DIMES); Nephrology, Dialysis and Renal Transplant Unit, St. Orsola University Hospital, University of Bologna, Italy.

Paolo Bruno (P)

Department of Experimental Diagnostic and Specialty Medicine (DIMES); Nephrology, Dialysis and Renal Transplant Unit, St. Orsola University Hospital, University of Bologna, Italy.

Diletta Conte (D)

Department of Experimental Diagnostic and Specialty Medicine (DIMES); Nephrology, Dialysis and Renal Transplant Unit, St. Orsola University Hospital, University of Bologna, Italy.

Marco Ruggeri (M)

Department of Experimental Diagnostic and Specialty Medicine (DIMES); Nephrology, Dialysis and Renal Transplant Unit, St. Orsola University Hospital, University of Bologna, Italy.

Maria Cappuccilli (M)

Department of Experimental Diagnostic and Specialty Medicine (DIMES); Nephrology, Dialysis and Renal Transplant Unit, St. Orsola University Hospital, University of Bologna, Italy.

Gaetano La Manna (G)

Department of Experimental Diagnostic and Specialty Medicine (DIMES); Nephrology, Dialysis and Renal Transplant Unit, St. Orsola University Hospital, University of Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH